Defending Pharmacy Liens Against 'Excessive Charges' Claims
James Wong — Founder & Pharmacist, LienScripts | March 3, 2026 | 10 min read
Insurance adjusters frequently label pharmacy lien charges as 'excessive' or 'unreasonable' during settlement negotiations. This rebuttal framework gives PI attorneys the statutory definitions, pricing methodology concepts, and template language to defend every dollar of the lien balance.
Defending Pharmacy Liens Against 'Excessive Charges' Claims
The "excessive charges" attack is the most common defense strategy against pharmacy liens in personal injury settlement negotiations. Adjusters assert that pharmacy lien amounts exceed what is "reasonable" and demand reductions based on retail pricing benchmarks that do not account for the services provided. This attack can be systematically dismantled using statutory definitions, recognized pricing frameworks, and documentation of the full scope of services rendered.
- The "excessive charges" argument relies on comparing lien pharmacy pricing to retail or insurance-negotiated rates — a comparison that ignores the fundamentally different service scope of lien-based pharmaceutical care
- "Reasonable" charges under most state statutes are evaluated based on services rendered, not on the cheapest available alternative
- Recognized pricing benchmarks (AWP, WAC, usual and customary) each have distinct definitions and limitations that attorneys must understand to counter adjuster arguments
- LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
- Template rebuttal language is provided below for demand letter responses addressing excessive charges claims
Defining "Reasonable" Under State Law
The foundation of every "excessive charges" rebuttal is the legal definition of "reasonable" charges for healthcare services. Adjusters often use "reasonable" as if it were synonymous with "cheapest available." It is not.
Under most state statutes governing personal injury damages, a plaintiff is entitled to recover the reasonable value of medical services rendered. Courts evaluate reasonableness by examining:
The nature and extent of services provided. A lien pharmacy delivers clinical pharmacist oversight, documentation, delivery coordination, refill management, and zero-upfront-cost financial risk assumption — services that a retail pharmacy does not provide.
The customary charges for similar services in the community. The relevant comparison is not retail pharmacy pricing — it is the charges of other lien-based healthcare providers offering comparable clinical and logistical services in the personal injury context.
The qualifications of the provider. Clinical pharmacist review, drug utilization management, and pharmacist-signed MERIT documentation represent professional services rendered by licensed healthcare providers.
The financial terms of the arrangement. The pharmacy extends credit to the patient for the duration of the case, assumes the risk of non-recovery, and defers payment until settlement. This financial arrangement has independent economic value.
According to James Wong, PharmD, founder of LienScripts, "Adjusters conflate 'reasonable' with 'retail.' But no retail pharmacy assumes the financial risk of a two-year case, provides clinical oversight for the full treatment duration, or produces pharmacist-signed documentation for demand packages. The services are different, and the pricing reflects that difference."
[!KEY] "Reasonable" under state law means the fair value of services actually rendered — not the lowest price available for a medication in isolation. The attorney's job is to define the comparison set correctly: lien-based pharmaceutical services, not retail pharmacy transactions.
Pricing Methodology Concepts: AWP, WAC, and Usual & Customary
Adjusters frequently invoke pricing benchmarks to argue that lien charges are excessive. Understanding these frameworks — and their limitations — is essential for effective rebuttal.
Average Wholesale Price (AWP)
AWP is a published benchmark that historically represented the average price at which wholesalers sell medications to pharmacies. In practice, AWP is a list price that does not reflect actual acquisition costs, negotiated discounts, or rebates. Courts and regulatory bodies have recognized that AWP is an imperfect benchmark — it has been described as the "sticker price" of pharmaceuticals.
Why adjusters cite it: AWP provides a published number that appears objective. Adjusters may argue that charges exceeding a percentage of AWP are per se unreasonable.
Why it fails as a ceiling: AWP does not account for clinical services, documentation, delivery, financial risk, or any other component of lien pharmacy care beyond the medication itself. Using AWP as a ceiling for lien charges is equivalent to arguing that a surgeon's fee should be capped at the cost of the surgical supplies used.
Wholesale Acquisition Cost (WAC)
WAC represents the manufacturer's list price to wholesalers before discounts or rebates. Like AWP, WAC is a published benchmark that does not reflect actual transaction prices and does not account for any service component.
Why adjusters cite it: WAC provides an even lower benchmark than AWP, allowing adjusters to characterize a larger gap as "excessive."
Why it fails: WAC captures the cost of the drug product alone. It says nothing about the value of clinical oversight, documentation, coordination, or financial risk assumption. No healthcare provider's charges are evaluated solely against their supply costs.
Usual and Customary (U&C)
Usual and customary pricing refers to what a pharmacy typically charges for a medication. In the insurance context, U&C rates are derived from aggregated claims data for cash-pay and insurance transactions.
Why adjusters cite it: U&C rates appear to represent "normal" pricing, making anything higher seem unusual.
Why it fails: U&C rates are calculated from retail and insurance transactions that involve a fundamentally different service scope. A lien pharmacy engagement includes services that no retail transaction includes. Comparing the two is comparing a hotel room rate to a short-term apartment rental that includes furnishings, utilities, housekeeping, and a concierge — the services are different, and so is the pricing.
[!KEY] AWP, WAC, and U&C are all drug-product benchmarks. None of them captures the value of clinical services, documentation, delivery coordination, or financial risk assumption. Attorneys should challenge any attempt to use these benchmarks as a ceiling for lien pharmacy charges.
Services Beyond the Medication
The strongest rebuttal to "excessive charges" is a detailed accounting of the services included in the lien engagement that no retail pharmacy provides:
Clinical pharmacist review. Every prescription is reviewed by a clinical pharmacist in the context of the patient's documented injuries, complete medication profile, and treatment plan. This is not a cursory check — it is an ongoing clinical engagement that identifies drug interactions, monitors therapeutic appropriateness, and flags adherence concerns.
MERIT documentation. The MERIT (Medication Evaluation & Rationale for Injury Treatment) report produced by LienScripts for every case provides a pharmacist-signed clinical narrative that ties each medication to the documented injury. This document supports the demand package and provides evidence of clinical necessity that retail pharmacy records cannot provide.
Zero-upfront-cost access. The patient pays nothing at the time of dispensing. The pharmacy carries the financial obligation for the duration of the case — often 12 to 24 months — and assumes the risk that recovery may be insufficient to cover the lien balance.
Refill management and adherence monitoring. The pharmacy actively manages refills, contacts patients regarding missed doses, and coordinates with prescribers to prevent treatment gaps. Treatment gaps are one of the most effective tools adjusters use to challenge causation, making proactive refill management a service that directly protects case value.
Medication delivery. Medications are delivered or shipped directly to patients, removing transportation barriers that can lead to treatment interruption.
Attorney portal and case tracking. LienScripts provides real-time portal access for attorneys to monitor dispensing history, lien balances, and case status throughout the engagement.
Case Law Supporting Lien Pharmacy Pricing
Courts across multiple jurisdictions have addressed the reasonableness of lien-based healthcare charges and have consistently applied several key principles:
The collateral source rule. In most states, the collateral source rule prevents the defense from reducing damages based on what a plaintiff could have paid through insurance or other sources. The lien amount — not the hypothetical insurance-negotiated rate — represents the value of services rendered.
Provider's right to charge for services rendered. Courts have upheld that healthcare providers operating under lien arrangements may charge rates that differ from insurance-negotiated rates, provided the charges reflect actual services rendered and are not unconscionable.
Financial risk premium is legitimate. Courts have recognized that providers who defer payment and assume collection risk are entitled to charge rates that reflect that financial arrangement. This principle applies across all lien-based healthcare services, including pharmacy.
The reasonable value standard, not the minimum cost standard. The legal standard is whether charges represent the reasonable value of services rendered — not whether the same medication could have been obtained at a lower price through a different service arrangement.
Template Rebuttal Language for Demand Responses
Addressing "Excessive Charges" in the Demand Letter
"[Carrier]'s characterization of the pharmacy lien balance as 'excessive' is based on a comparison to retail pharmacy pricing that does not account for the scope of services rendered.
[Patient Name] received comprehensive lien-based pharmaceutical services over [X] months of treatment, including: clinical pharmacist oversight of the complete medication regimen; pharmacist-signed MERIT documentation supporting medical necessity for each prescribed medication; medication delivery coordination; proactive refill management and adherence monitoring; and zero-upfront-cost medication access without the delays, denials, and formulary restrictions associated with health insurance billing.
The pharmacy lien balance of [amount] reflects the reasonable value of these services as rendered by a licensed pharmacy operating under a valid lien agreement. Under [State] law, a plaintiff is entitled to recover the reasonable value of medical services rendered, which is not limited to the lowest available price for the medication component alone.
[Carrier]'s reliance on [AWP/U&C/retail] pricing as a benchmark ignores the clinical, logistical, and financial services that are integral to the lien pharmacy engagement. We note that hospitals, physicians, and other lien-based providers routinely charge rates that exceed insurance-negotiated benchmarks, and their charges are evaluated under the same 'reasonable value of services rendered' standard.
We are prepared to provide complete documentation of the services rendered, including dispensing records, clinical review notes, MERIT documentation, and delivery records."
[!KEY] Template language should always (1) enumerate the services rendered, (2) identify the correct legal standard, (3) explain why the adjuster's benchmark is inapplicable, and (4) offer documentation. Never concede that retail pricing is a valid comparison set.
Pre-Negotiation Preparation Checklist
Before entering settlement negotiations where pharmacy lien charges will be contested, attorneys should assemble:
- Complete dispensing records from the LienScripts attorney portal
- MERIT report for the case
- Timeline of treatment showing the relationship between injury dates and prescription dates
- Documentation of any refill management interventions or clinical consultations
- Delivery records
- Relevant state statute language defining "reasonable" charges for medical services
- One-page summary of the "services rendered" framework for the adjuster
Frequently Asked Questions
Q: What if the adjuster demands an itemized cost breakdown for each medication?
A: The reasonableness of healthcare charges is evaluated based on the value of services rendered, not on the provider's cost basis. No hospital, physician, or healthcare provider is required to disclose cost basis to establish the reasonableness of charges. The appropriate response is to provide documentation of the services rendered — dispensing records, clinical review notes, MERIT documentation, and delivery records — not internal cost data.
Q: Can the adjuster reduce the lien balance without the pharmacy's consent?
A: No. The pharmacy lien is a contractual agreement between the patient and the pharmacy, creating a legal interest in the settlement proceeds. The adjuster cannot unilaterally reduce the lien amount. Any reduction requires negotiation with the lienholder.
Q: What if the adjuster argues that the patient should have used health insurance?
A: Health insurance billing introduces formulary restrictions, prior authorization delays, step therapy requirements, and subrogation claims — all of which can delay treatment, limit medication access, and reduce net patient recovery. The lien arrangement provided uninterrupted access to clinically appropriate medications, and the collateral source rule in most states prevents the defense from reducing damages based on available insurance.
Q: How do courts typically rule on "excessive charges" challenges?
A: Courts generally evaluate healthcare charges under a "reasonable value of services rendered" standard that considers the nature and extent of services, the provider's qualifications, customary charges for similar services, and the financial terms of the arrangement. Courts have consistently held that lien-based charges may exceed insurance-negotiated rates when the provider demonstrates a broader scope of services.
Related Resources
- Pharmacy Lien Pricing Explained: An Attorney's Guide
- Top Adjuster Attacks on Pharmacy Liens — And How to Rebut Them
- Made Whole Doctrine and Pharmacy Liens in California
Frequently Asked Questions
What if the adjuster demands an itemized cost breakdown for each medication?
The reasonableness of healthcare charges is evaluated based on the value of services rendered, not on the provider's cost basis. Provide documentation of services rendered — dispensing records, clinical review notes, MERIT documentation, and delivery records — not internal cost data.
Can the adjuster reduce the lien balance without the pharmacy's consent?
No. The pharmacy lien is a contractual agreement between the patient and the pharmacy, creating a legal interest in the settlement proceeds. The adjuster cannot unilaterally reduce the lien amount. Any reduction requires negotiation with the lienholder.
What if the adjuster argues that the patient should have used health insurance?
Health insurance billing introduces formulary restrictions, prior authorization delays, step therapy requirements, and subrogation claims. The lien arrangement provided uninterrupted access to clinically appropriate medications, and the collateral source rule prevents the defense from reducing damages based on available insurance.
How do courts typically rule on 'excessive charges' challenges?
Courts generally evaluate healthcare charges under a reasonable value of services rendered standard that considers the nature and extent of services, the provider's qualifications, customary charges for similar services, and the financial terms of the arrangement.